The influence of culture conditions on the biosynthesis of secondary metabolites by Penicillium verrucosum Dierck

Microbiological Research

Volumn 161, Issue 3, 2006, Pages 273-280

  Elias, Barbara Casellato ^a   Said, Suraia ^a   de Albuquerque, Sérgio ^b   Pupo, Mônica Tallarico ^a  

^a Departamento de Ciências Farmacêuticas   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chemical profiles; Culture conditions; Penicillium verrucosum; Secondary metabolites; Trypanocidal activity

Indexed keywords

CELLS; FERMENTATION; METABOLISM; METABOLITES; NUTRITION;

CHEMICAL PROFILES; CULTURE CONDITIONS; PENICILLIUM VERRUCOSUM; SECONDARY METABOLITES; TRYPANOCIDAL ACTIVITY;

BIOSYNTHESIS;

BIOLOGICAL PRODUCTION; CULTIVATION; FERMENTATION; FUNGUS; INCUBATION; NUTRIENT; SECONDARY METABOLITE;

PENICILLIUM; PENICILLIUM VERRUCOSUM; TRYPANOSOMA CRUZI;

EID: 33744790274     PISSN: 09445013     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micres.2005.10.003     Document Type: Article

References (26)

1. Alviano C.S., Farbiarz S.R., Travassos L.R., Angluster J., and Souza W. Effect of environmental factors on Fonsecaea pedrosoi morphogenesis with emphasis on sclerotic cells induced by propanolol. Micopathologia 119 (1992) 17-23
2. Brenner Z. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev. Inst. Med. Trop. 4 (1962) 389-396
3. Coura J.R., and Castro S.L. A critical review on Chagas disease chemotherapy. Mem. Inst. Oswaldo Cruz 97 (2002) 3-24
4. Demain A.L. Pharmaceutically active secondary metabolites of microorganisms. Appl. Microbiol. Biotechnol. 52 (1999) 455-463
5. Demain A.L. Microbial biotechnology. Trends Biotechnol. 18 (2000) 26-31
6. Freitas T.P.S., Furtado N.A.J.C., Bastos J.K., and Said S. Active substances against trypomastigote forms of Trypanosoma cruzi and microorganisms are produced in sequence by Talaromyces flavus. Microbiol. Res. 157 (2002) 201-206
7. Furtado N.A.J.C., Said S., Ito I.Y., and Bastos J.K. The antimicrobial activity of Aspergillus fumigatus is enhanced by a pool of bacteria. Microbiol. Res. 157 (2002) 207-211
8. Gaden E.L. Fermentation process kinetics. J. Biochem. Microbiol. Technol. Eng. I 1 (2000) 413-418
9. Georgiou C.D. Lipid peroxidation in Sclerotium rolfsii: a new look into the mechanism of sclerotial biogenesis in fungi. Mycol. Res. 101 (1997) 460-464
10. Göhrt A., and Zeeck A. Secondary metabolites by chemical screening. 9 Decarestrictines, a new family of inhibitors of cholesterol biosynthesis from Penicillium. J. Antibiot. (1992) 66-73
11. Jackson M., Karwoswski J.P., Humphrey P.E., Kohl W.L., Barlow G.J., and Tanaka S.K. Calbistrins, novel antifungal agents produced by Penicillium restrictum. J. Antibiot. 46 (1993) 34-38
12. Kwon O.S., Park S.H., Yun B.S., Pyun Y.R., and Kim C.J. Cyclo(dehydroala-l-Leu) an α-glucosidase inhibitor from Penicillium sp. F70614. J. Antibiot. 53 (2000) 954-958
13. Larsen T.O., Frydenvang K., and Frisvad J.C. UV-guided screening of benzodiazepine producing species in Penicillium. Biochem. Syst. Ecol. 28 (2000) 881-886
14. Magnusson J., and Schnürer J. Lactobacillus coryniformis subsp. coryniforms Strain Si3 produces a broad-spectrum proteinaceous antifungal compound. Appl. Environ. Microbiol. 67 (2001) 1-5
15. Malmstrom J., Christophersen C., and Frisvad J. Secondary metabolites characteristic of Penicillium citrinum, Penicillium steckii and related species. Phytochemistry 54 (2000) 301-309
16. Medentsev A.G., and Akimenko V.K. Fungal naphthoquinone metabolites. Appl. Biochem. Microbiol. 32 (1996) 7-29
17. Nam J., Kim H., Kwon J., Han M.Y., Son K., Lee U.C., Choi J., and Know B. 8-O-Methylsclerotiorinamine, antagonist of the Grb2-SH2 domain, isolated from Penicillium multicolor. J. Nat. Prod. 63 (2000) 1303-1305
18. Pearce C. Biologically active fungal metabolites. Adv. Appl. Microbiol. 44 (1997) 1-80
19. Silva L.H.P., and Nussenzweig V. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco. Folia Clin. Biol. 20 (1953) 191-198
20. Silva M.G., Furtado N.A.J.C., Pupo M.T., Fonseca M.J.V., Said S., Silva-Filho A.A., and Bastos J.K. Antibacterial activity from Penicillium corylophilum Dierckx. Microbiol. Res. 159 (2004) 317-322
21. Takeuchi M., Nakajima M., Ogita T., Inukai M., Kodama K., Furuya K., Nagaki H., and Haneishi T. Fosfonocholorin, a new antibiotic with spheroplast forming activity. J. Antibiot. 42 (1989) 198-205
22. Thrane C., Kaufmann U., Stummann B.M., and Olsson S. Activation of caspase-like activity and poly (ADP-ribose) polymerase degradation during sporulation in Aspergillus nidulans. Fungal Genet. Biol. 41 (2004) 361-368
23. Umar M.H., and Van Griensven L.J.L.D. Morphogenetic cell death in developing primordia of Agaricus bisporus. Mycologia 89 (1997) 274-277
24. Urbina J.A., and Docampo R. Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol. 19 (2003) 495-501
25. Uren A.G., O'Rourke K., Aravind L., Pisabarro M.T., Seshagiri S., Koonin E.V., and Dixit V.M. Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma. Mol. Cell 6 (2000) 961-967
26. Vogel H.J. A convenient medium for Neurospora (medium N). Microbiol. Gen. Bull. 13 (1956) 42-43